Vasireddi and colleagues at the Hospital for Special Surgery published the most rigorous accounting of BPC-157 literature to date in 2025
Counteracts NSAID Damage BPC-157 has been uniquely shown to reverse the gastrointestinal damage caused by NSAIDs (ibuprofen, naproxen, aspirin)
Two downstream consequences are mechanistically central: nicotinamide is preserved for re-entry into the NAD+ salvage pathway (raising intracellular NAD+ availability), and SAM is preserved for other methylation reactions
Peptide Degradation and Contamination Risk: BPC-157 sourced from unregulated research suppliers carries the risk of contamination, incorrect peptide sequencing, or degraded compound from improper storage, introducing unpredictable biological effects beyond the peptide's known pharmacology
Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes (review)
Peptide reconstitution solution, such as bacteriostatic water, is specifically formulated for dissolving freeze-dried peptides in research settings
